Abstracts Archive - Page 1287 of 2425 - ACR Meeting Abstracts

Abstract Number: 1222 • 2017 ACR/ARHP Annual Meeting
Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France
Marion Geoffroy¹, Isabelle Lambrecht¹, Jan Chrusciel², Isabelle Gaubil-Kaladjian³, Ana Diaz-Cives⁴, Jean Paul Eschard¹ and Jean-Hugues Salmon¹, ¹Service de Rhumatologie, CHU Reims, Hôpital Maison Blanche, Reims, France, ²Service de Recherche Clinique, CHU Reims, Hôpital Robert Debré, Reims, France, ³Service d’Endocrinologie et nutrition, CHU Reims, Hôpital Robert Debré, Reims, France, ⁴Service de chirurgie digestive, CHU Reims, Hôpital Robert Debré, Reims, France
Background/Purpose: Bariatric surgery is used to treat severe obesity. We aimed to investigate the incidence of significant bone mineral density (BMD) loss at 6 and…
Abstract Number: 1223 • 2017 ACR/ARHP Annual Meeting
Inflammatory Bowel Diseases and the Risks of Fracture and Low Mineral Density: Review of the Literature and Meta-Analysis of Observational Cohorts
Paulina Szafors¹, Thomas Barnetche², Cédric Lukas³, Jacques Morel⁴, Cécile Gaujoux-Viala^5,6, Bernard Combe⁷ and Hélène Che⁸, ¹Department of Rheumatology, Lapeyronie Hospital and University of Montpellier, Montpellier, France, ²Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, ³Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, ⁴Rheumatology, CHU Lapeyronie and Montpellier University, Montpellier, France, ⁵Rheumatology, Nîmes University Hospital and EA2415 Montpellier University, Nîmes, France, ⁶EA 2415, Montpellier University, Nîmes, France, ⁷Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, ⁸Rheumatology, University and Hospital Lapeyronie, University of Montpellier, France
Background/Purpose: Inflammatory bowel diseases (IBD), such as Crohn disease (CD) and ulcerative colitis (UC), are associated with a decreased bone mineral density caused by chronic…
Abstract Number: 1224 • 2017 ACR/ARHP Annual Meeting
BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment
Eztizen Labrador Sanchez¹, Elena Grau Garcia¹, Karla Arevalo Ruales¹, Jorge Juan Fragio Gil¹, Roxana Gonzalez Mazario¹, Cristina Alcañiz Escandell¹, Ines Canovas Olmos¹, Inmaculada Chalmeta Verdejo¹, Carlos Feced Olmos¹, Luis Gonzalez Puig¹, Jose Ivorra Cortes¹, Isabel Martinez Cordellat¹, Carmen Najera Herranz¹, Rosa Negueroles Albuixech¹, Jose Eloy Oller Rodriguez¹, Francisco Miguel Ortiz-Sanjuán¹, Elvira Vicens Bernabeu¹, Victoria Fornes Ferrer², David Hervás Marín², Marta De la Rubia Navarro¹, Angel Moya Herraiz³ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Biostatistics Unit. IIS La Fe, Valencia, Spain, ³Hepatology Department. Hospital Universitario y politecnico La Fe, Valencia, Spain
Background/Purpose: Osteoporosis is a frequent complication in patients with chronic liver diseases, mainly in advanced stages or with evidence of cholestasis. During the first few…
Abstract Number: 1225 • 2017 ACR/ARHP Annual Meeting
BONE Mineral Density and Vertebral Fractures in Gaucher Disease Patients Treated with Imiglucerase
Maria Silvia Larroude¹, Gabriel Aguilar¹, Ignacio Rossi¹, Lucas Ricardo Brun² and Guillermo Drelichman³, ¹Centro de Diagnostico Rossi, Buenos Aires, Argentina, ²School of Medicine. Rosario National University, Bone Biology Laboratory, Rosario, Argentina, ³Hospital Ricardo Gutierrez, Buenos Aires, Argentina
Background/Purpose: Osteopenia and osteoporosis (OP) have been described in patients with Gaucher disease (GD) but there are very few reports about bone mass in GD…
Abstract Number: 1226 • 2017 ACR/ARHP Annual Meeting
Association of Dorsal Flat Vertebra/Platyspondylia As a Form of Vertebral Dysplasia within Type II Collage Disorders
Pilar Ahijado-Guzman¹, Raul Veiga², Miguel Cantalejo¹, Justo Ruiz³ and Antonio Zapatero³, ¹Rheumatology Unit. Fuenlabrada’s Hospital, Madrid, Madrid, Spain, ²Rheumatology Unit. Fuenlabrada’s Hospital, Madrid, Fuenlabrada, Spain, ³Department of Internal Medicine. Fuenlabrada’s Hospital, Madrid, Madrid, Spain
Background/Purpose: Defects in the type II collagen gene are described. These predispose humans to various phenotypic combinations in families with skeletal dysplasia, and/or disease by…
Abstract Number: 1227 • 2017 ACR/ARHP Annual Meeting
Osteoporosis and Breast Cancer: Can FRAX-Based Risk Factors Accurately Predict Further Fractures at This Setting?
Salvador López-Salguero¹, Laura Ranieri², Juan Carlos Ordoñez³, Mariano Andrés^4,5, Jose Ponce⁶ and Isabel Ibero², ¹Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain, ²Reumatología, Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, ³RHEUMATOLOGY, Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, ⁴Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, ⁵Universidad Miguel Hernández, Elche, Spain, ⁶Oncología, Dpt. Oncology, Hospital General Universitario Alicante, Alicante, Spain
Background/Purpose: Women with breast cáncer (BC) are at risk for the development of bone loss and osteoporosis (OP) mainly due to adjuvant therapies, as aromatase…
Abstract Number: 1228 • 2017 ACR/ARHP Annual Meeting
Postmenopausal Breast Cancer Patients on Aromatase Inhibitor Therapy and Their Increased Risk of Fragility Fracture
Anna Lafian¹, Julia Suh² and Karina Torralba³, ¹Internal Medicine, Arrowhead Regional Medical Center, Colton, CA, ²Internal Medicine, Loma Linda University, Loma Linda, CA, ³Internal Medicine/Rheumatology, Loma Linda University, Loma Linda, CA
Background/Purpose: Postmenopausal women with breast cancer have higher osteoporosis risk due to declining estrogen levels and use of aromatase inhibitors (AIs). The American Society of…
Abstract Number: 1229 • 2017 ACR/ARHP Annual Meeting
Factors Affecting FRAX Score Calculation & Treatment in Practice
Avneet Vig¹, Beverly Johnson², Tony Francis³ and Barbara Mendez-Agrusa⁴, ¹Montefiore Medical Center, Bronx, NY, ²Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, ³Radiology, Albert Einstein College of Medicine, Bronx, NY, ⁴Medicine, Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Osteoporosis-related fractures causes increased disability and morbidity and mortality. The FRAX algorithm quantifies the 10 year probability of a hip or major osteoporotic fracture.…
Abstract Number: 1230 • 2017 ACR/ARHP Annual Meeting
Comparative Study of Frax® Score in Ecuadorian Population
Genessis Maldonado¹, Carlos Paredes¹, Roberto Guerrero¹, Maricarmen Mieles¹, Maria Jose Intriago¹, O Messina² and Carlos Ríos³, ¹Universidad Espiritu Santo, Guayaquil, Ecuador, ²Hospital Argerich, Buenos Aires, Argentina, ³Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador
Background/Purpose: Osteoporosis is a systemic skeletal disease characterized by a decrease in bone mineral density with alterations in bone microarchitecture and an increased risk of…
Abstract Number: 1231 • 2017 ACR/ARHP Annual Meeting
Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence
Ayano Kelly^1,2,3,4, Daniel Sumpton^3,5,6, Clare O'Sullivan², Alexa Meara⁷, Robby Nieuwlaat⁸, Peter Tugwell^9,10,11, Lyn March^12,13,14, Allison Tong^3,6, Karine Toupin-April¹⁵, Francois Nantel¹⁶, B.J.F. Van den Bemt (PharmD, PhD)^17,18, Mary De Vera¹⁹, Vicki Evans²⁰, Willemina Campbell²¹, Peter Wong²², Rebecca Davey²³, Dorcas Beaton^24,25,26, Maria Suarez-Almazor^27,28,29,30, Geraldine Hassett^31,32, Helen I. Keen^33,34,35, Therese Dawson³⁶, Luke Crimston-Smith³⁷ and Kathleen Tymms³⁸, ¹Rheumatology, Canberra Rheumatology, Canberra, Australia, ²Rheumatology, The Canberra Hospital, Canberra, Australia, ³Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia, ⁴School of Medicine, Australian National University, Canberra, Australia, ⁵Department of Rheumatology, Concord Hospital, Sydney, Australia, ⁶Sydney School of Public Health, University of Sydney, Sydney, Australia, ⁷Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, ⁸Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada, ⁹Center For Global Health, Institute of Population Health, Ottawa, ON, Canada, ¹⁰Institute of Population Health, Center For Global Health, University of Ottawa, Ottawa General Hospital, Ottawa, ON, Canada, ¹¹Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada, ¹²Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, ¹³Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ¹⁴Rheumatology, University of Sydney, Insitute of Bone and Joint Research, Royal North Shore Hospital, St Leonards NSW, Australia, ¹⁵Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, ¹⁶Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹⁷Pharmacy, Sint Maartenskliniek and Radboudumc, Nijmegen, Netherlands, ¹⁸Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands, ¹⁹Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada, ²⁰Clear Vision Consulting, Canberra, Australia, ²¹Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ²²Mid-North Coast Arthritis Clinic and University of New South Wales Rural Clinical School, Coffs Harbour, Australia, ²³Arthritis ACT, Canberra, Australia, ²⁴Research, Mobility Program Clinical Research Unit, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada, ²⁵Scientist, Institute for Work & Health, Toronto, ON, Canada, ²⁶Mobility Program Clinical Research Unit, St Michael's Hospital, Toronto, ON, Canada, ²⁷GIM, AT & EC, UT MD Anderson Cancer Center, Houston, TX, ²⁸Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, ²⁹Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine,, The University of Texas MD Anderson Cancer Center, Houston, TX, ³⁰The University of Texas MD Anderson Cancer Center, Houston, TX, ³¹Rheumatology, Liverpool Hospital, Sydney, Australia, ³²Ingham Institute, Sydney, Australia, ³³Rheumatology, Royal Perth Hospital, Perth, Australia, ³⁴Leeds, Leeds, United Kingdom, ³⁵School of Medicine and Pharmacology, University of Western Australia, Perth, Australia, ³⁶Rheumatology, Lord Street Specialist Centre, Port Macquarie, Australia, ³⁷Australian National University, Canberra, Australia, ³⁸ANU, Canberra, Australia
Background/Purpose: Poor medication adherence attenuates optimal clinical benefits and reduces the overall effectiveness of health systems. A large number of interventions targeting medication adherence have…
Abstract Number: 1232 • 2017 ACR/ARHP Annual Meeting
The Perceived Impact of Recent-Onset Psoriatic Arthritis Is Different between Genders: A Spanish Multicenter Experience
Rubén Queiro¹, Ana Laiz², Carlos Alberto Montilla-Morales³, Eva Galindez-Agirregoikoa⁴, Juan J. Bethencourt⁵ and Daniel Seoane⁶, ¹Rheumatology Department. Hospital Universitario Central de Asturias, Oviedo, Spain, ²Rheumatology, HU. Santa Creu i San Pau, Barcelona, Spain, ³Hospital Clínico Universitario de Salamanca, Salamanca, Spain, ⁴Rheumatology Division, Hospital Universitario de Basurto, Bilbao, Spain, ⁵Rheumatology, HU. Canarias, Sta. Cruz de Tenerife, Spain, ⁶Research Unit, Spanish Foundation of Rheumatology, Madrid, Spain
Background/Purpose: Some studies point to a differential clinical expression between men and women with PsA, but the information on gender differences is very scarce in…
Abstract Number: 1233 • 2017 ACR/ARHP Annual Meeting
Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience
Narender Annapureddy¹, Michelle J. Ormseth², Julie Barnes³ and James Gore⁴, ¹Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, ²Rheumatology, Vanderbilt Medical Center, Nashville, TN, ³Vanderbilt University Medical Center, Nashville, TN, ⁴Vanderbilt Rheumatology Cool Springs, Franklin, TN
Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience Background/Purpose: In 2015, about 16% of adults under age 65 in Tennessee were uninsured.…
Abstract Number: 1234 • 2017 ACR/ARHP Annual Meeting
How Machine Learning Statistics Can Change the Game of Data Analysis in Rheumatology: The Example a Study with 170 Patients with Rheumatoid Arthritis (ra) or Axial Spondyloarthritis (axspa)
Frédéric Guyard¹, Laure Gossec², Didier Leroy³, Thomas Lafargue¹, Michel Seiler³, Charlotte Jacquemin⁴, Anna Molto⁵, Jeremie Sellam⁶, Violaine Foltz⁴, Frédérique Gandjbakhch⁴, Christophe Hudry⁷, Stéphane Mitrovic⁴, Bruno Fautrel⁴ and Herve Servy⁸, ¹IMT, Orange, Nice, France, ²UPMC, University Paris 06, Pitié-Salpétrière Hospital, Paris, France, ³Healthcare, Orange, Paris, France, ⁴UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, ⁵Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ⁶Rheumatology, Saint-Antoine Hospital, Paris, France, ⁷AP-HP Hôpital Cochin, Paris, France, ⁸e-health services, Sanoia, Gemenos, France
Background/Purpose: A link between flares and physical activity would confirm the objective consequences of flares. In the ActConnect study of patients with RA or axSpA,…
Abstract Number: 1235 • 2017 ACR/ARHP Annual Meeting
Perceived Stress and Fatigue in Systemic Lupus Erythematosus
Patricia P. Katz¹, Desiree R Azizoddin² and Meenakshi Jolly³, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²Department of Medicine and Behavioral Sciences, Rush University, Chicago, IL, ³Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Fatigue is a common and often severe symptom among individuals with systemic lupus erythematosus (SLE). Yet, there is an incomplete understanding of the causes…
Abstract Number: 1236 • 2017 ACR/ARHP Annual Meeting
The Influence of Testimonials on Patient Decision-Making
Changchuan Jiang¹, Ellen Peters² and Liana Fraenkel³, ¹Yale University, New Haven, CT, ²Decision Research, Eugene, OR, ³Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT
Background/Purpose: Testimonials have been shown to have a strong influence on patient decision-making. Patients are increasingly accessing the Internet as a source of medical information.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].